Literature DB >> 34048764

Chemoradiation Therapy as Definitive Treatment of Esophageal Cancer.

Sue Xue Wang1, M Blair Marshall2.   

Abstract

Definitive chemoradiation therapy avoids the perioperative and long-term morbidity of esophagectomy and is the standard of care for cervical esophageal cancer. There are significant differences in tumor response to chemoradiation and recurrence patterns between squamous cell cancer and adenocarcinoma of the esophagus. Multimodality therapy for esophageal cancer continues to progress, now with the widespread use of PET scanning and possible active surveillance in patients with complete clinical response to chemoradiation. As drug development and targeted therapy trials continue to expand, our understanding of tumor biology and precision medicine will continue to refine the treatment of esophageal cancer.
Copyright © 2021 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Definitive chemoradiation; Esophageal carcinoma; Immunotherapy; Multimodality therapy

Year:  2021        PMID: 34048764     DOI: 10.1016/j.suc.2021.03.006

Source DB:  PubMed          Journal:  Surg Clin North Am        ISSN: 0039-6109            Impact factor:   2.741


  2 in total

1.  Machine Learning and Novel Biomarkers Associated with Immune Infiltration for the Diagnosis of Esophageal Squamous Cell Carcinoma.

Authors:  Jipeng Zhang; Nian Zhang; Xin Yang; Xiangbin Xin; Cheng-Hui Jia; Sen Li; Qiang Lu; Tao Jiang; Tao Wang
Journal:  J Oncol       Date:  2022-08-30       Impact factor: 4.501

2.  A Nomogram for Predicting the Risk of Radiotherapy-Related Esophageal Fistula in Esophageal Cancer Patients.

Authors:  Zhongxuan Gui; Huiquan Liu; Weijiong Shi; Yuechen Xu; Han Qian; Fan Wang
Journal:  Front Oncol       Date:  2022-01-18       Impact factor: 6.244

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.